| S1218 |
Clofarabine
|
Clofarabine (Clolar) inhibits the enzymatic activities of ribonucleotide reductase (RNR) (IC50 = 65 nM) and DNA polymerase. Clofarabine induces autophagy and apoptosis.
|
-
Investigative Ophthalmology & Visual Science, 2025, 42
-
Invest Ophthalmol Vis Sci, 2025, 66(5):42
-
bioRxiv, 2025, 2025.04.25.650475
|
|
| S0283 |
COH-29
|
COH29 (RNR Inhibitor COH29) is a potent inhibitor of ribonucleotide reductase (RNR) with anticancer activity. COH29 (RNR Inhibitor COH29) inhibits recombinant RNR small subunit (RRM1/RRM2) activity in vitro with IC50 of 16 μM.
|
-
Adv Sci (Weinh), 2021, e2100881
-
Advanced Science, 2021, e2100881
|
|
| S3385 |
NSAH
|
NSAH (HNASH) is a reversible and competitive nonnucleoside ribonucleotide reductase (RNR) inhibitor, with cell-free IC50 of 32 μM and cell-based IC50 of ~250 nM, respectively.
|
-
Pharmaceutics, 2022, 14-71387
|
|
| S7470 |
Triapine (3-AP)
|
Triapine (3-AP) is a potent ribonucleotide reductase (RNR) inhibitor with broad spectrum antitumor activity by inhibiting DNA synthesis. Phase 2.
|
-
Anticancer Research, June 2021, 2795-2804
-
OncoTargets and Therapy, April 2019, 3267-3275
-
iScience, 2024, 27(10):110862
|
|
| S3641 |
Osalmid
|
Osalmid suppresses ribonucleotide reductase (RNR) activity in a concentration-dependent manner, with a 50% RR activity-inhibitory concentration (IC50) of 8.23 μM.
|
-
Cell Commun Signal, 2026, 24(1)216
|
|